Clinical Trial Update: How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance

View source ↗

Summary

A completed NIH-sponsored clinical trial investigates how loss of dopamine and dopamine-restoring medications affect movement performance in Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Status: COMPLETED